TY - JOUR
T1 - Alternative splicing of the RAGE cytoplasmic domain regulates cell signaling and function
AU - Jules, Joel
AU - Maiguel, Dony
AU - Hudson, Barry I.
N1 - Copyright:
Copyright 2014 Elsevier B.V., All rights reserved.
PY - 2013/11/8
Y1 - 2013/11/8
N2 - The Receptor for Advanced Glycation End-products (RAGE) is a multi-ligand receptor present on most cell types. Upregulation of RAGE is seen in a number of pathological states including, inflammatory and vascular disease, dementia, diabetes and various cancers. We previously demonstrated that alternative splicing of the RAGE gene is an important mechanism which regulates RAGE signaling through the production of soluble ligand decoy isoforms. However, no studies have identified any alternative splice variants within the intracellular region of RAGE, a region critical for RAGE signaling. Herein, we have cloned and characterized a novel splice variant of RAGE that has a truncated intracellular domain (RAGEDICD). RAGEDICD is prevalent in both human and mouse tissues including lung, brain, heart and kidney. Expression of RAGEDICD in C6 glioma cells impaired RAGE-ligand induced signaling through various MAP kinase pathways including ERK1/2, p38 and SAPK/JNK. Moreover, RAGEDICD significantly affected tumor cell properties through altering cell migration, invasion, adhesion and viability in C6 glioma cells. Furthermore, C6 glioma cells expressing RAGEDICD exhibited drastic inhibition on tumorigenesis in soft agar assays. Taken together, these data indicate that RAGEDICD represents a novel endogenous mechanism to regulate RAGE signaling. Significantly, RAGEDICD could play an important role in RAGE related disease states through down regulation of RAGE signaling.
AB - The Receptor for Advanced Glycation End-products (RAGE) is a multi-ligand receptor present on most cell types. Upregulation of RAGE is seen in a number of pathological states including, inflammatory and vascular disease, dementia, diabetes and various cancers. We previously demonstrated that alternative splicing of the RAGE gene is an important mechanism which regulates RAGE signaling through the production of soluble ligand decoy isoforms. However, no studies have identified any alternative splice variants within the intracellular region of RAGE, a region critical for RAGE signaling. Herein, we have cloned and characterized a novel splice variant of RAGE that has a truncated intracellular domain (RAGEDICD). RAGEDICD is prevalent in both human and mouse tissues including lung, brain, heart and kidney. Expression of RAGEDICD in C6 glioma cells impaired RAGE-ligand induced signaling through various MAP kinase pathways including ERK1/2, p38 and SAPK/JNK. Moreover, RAGEDICD significantly affected tumor cell properties through altering cell migration, invasion, adhesion and viability in C6 glioma cells. Furthermore, C6 glioma cells expressing RAGEDICD exhibited drastic inhibition on tumorigenesis in soft agar assays. Taken together, these data indicate that RAGEDICD represents a novel endogenous mechanism to regulate RAGE signaling. Significantly, RAGEDICD could play an important role in RAGE related disease states through down regulation of RAGE signaling.
UR - http://www.scopus.com/inward/record.url?scp=84892506431&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84892506431&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0078267
DO - 10.1371/journal.pone.0078267
M3 - Article
C2 - 24260107
AN - SCOPUS:84892506431
VL - 8
JO - PLoS One
JF - PLoS One
SN - 1932-6203
IS - 11
M1 - e78267
ER -